Fletcher Aaron G.L.

CIK 00017894908 companiesFORT WORTH, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001789490

Recent Transactions

50 trades

Award
COGNITION THERAPEUTICS INC$CGTX
Common Stock
2026-06-17+25,000→ 81,229 total
Award
ACTUATE THERAPEUTICS, INC.$ACTU
Stock Options
2026-05-21+15,000→ 15,000 total
Exercise/Conversion
COGNITION THERAPEUTICS INC$CGTX
Common Stock
2025-09-19$0.84/sh+7,729→ 56,229 total
Exercise/Conversion
COGNITION THERAPEUTICS INC$CGTX
Stock Option (right to buy)
2025-09-19−7,729→ 0 total
Purchase
ACTUATE THERAPEUTICS, INC.$ACTU
Warrant (Right to Buy)
2025-06-27+71,428→ 71,428 total
Purchase
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2025-06-27$7.00/sh+71,428→ 196,428 total
Award
COGNITION THERAPEUTICS INC$CGTX
Common Stock
2025-06-18+34,000→ 48,500 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-13$3.09/sh−1,903→ 49,957 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-13$3.09/sh−14,218→ 373,178 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-13$3.09/sh−12,319→ 323,335 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-13$3.09/sh−4,354→ 114,272 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-13$3.09/sh−7,206→ 189,117 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-12$3.38/sh−18,678→ 335,654 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-12$3.38/sh−10,925→ 196,323 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-12$3.38/sh−21,557→ 387,396 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-12$3.38/sh−2,886→ 51,860 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-12$3.38/sh−6,601→ 118,626 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-11$3.40/sh−45→ 54,746 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-11$3.40/sh−171→ 207,248 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-11$3.40/sh−103→ 125,227 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-11$3.40/sh−293→ 354,332 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-11$3.40/sh−338→ 408,953 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-10$3.40/sh−3→ 207,419 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-10$3.40/sh−5→ 354,625 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-10$3.40/sh−5→ 409,291 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-10$3.40/sh−1→ 54,791 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-06-10$3.40/sh−2→ 125,330 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-29$3.03/sh−6,221→ 354,630 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-29$3.03/sh−7,180→ 409,296 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-29$3.03/sh−3,639→ 207,422 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-29$3.03/sh−961→ 54,792 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-29$3.03/sh−2,199→ 125,332 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-28$2.87/sh−4,620→ 360,851 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-28$2.87/sh−2,702→ 211,061 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-28$2.87/sh−1,632→ 127,531 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-28$2.87/sh−714→ 55,753 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-28$2.87/sh−5,332→ 416,476 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-27$3.05/sh−6,479→ 365,471 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-27$3.05/sh−1,000→ 56,467 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-27$3.05/sh−3,790→ 213,763 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-27$3.05/sh−7,478→ 421,808 total
Sale
Lantern Pharma Inc.$LTRN
Common Stock
2025-05-27$3.05/sh−2,290→ 129,163 total
Award
ACTUATE THERAPEUTICS, INC.$ACTU
Stock Options
2025-05-22+15,000→ 15,000 total
Other
IN8BIO, INC.$INAB
Series A Warrant
2025-05-02−574,241→ 0 total
Purchase
IN8BIO, INC.$INAB
Pre-Funded Warrants
2025-05-02+1,148,482→ 2,431,763 total
Other
IN8BIO, INC.$INAB
Series B Warrant
2025-05-02−574,241→ 0 total
Disposition to Issuer
IN8BIO, INC.$INAB
Series A Warrant
2024-10-04+574,241→ 0 total
Purchase
IN8BIO, INC.$INAB
Pre-Funded Warrants
2024-10-04+709,040→ 1,283,281 total
Purchase
IN8BIO, INC.$INAB
Series C Warrant
2024-10-04+709,040→ 709,040 total
Award
IN8BIO, INC.$INAB
Series A Warrant
2024-10-04+574,241→ 574,241 total

Companies

Recent Filings

Address

C/O BIOS EQUITY PARTNERS 1751 RIVER RUN, SUITE 400

FORT WORTH, TX, 76107

View on SEC.gov